Ostendorf P, Ehninger G, Schmidt H, Haen M, Link H, Schüch K, Müller C A, Wernet P, Dopfer R, Klingenbiel T
Dtsch Med Wochenschr. 1986 Apr 11;111(15):571-6. doi: 10.1055/s-2008-1068491.
Bone marrow transplantations were performed on 15 patients (aged 5-39 years) with severe aplastic anaemia. Twelve patients are alive 76-1930 days (median 668 d) after transplantation, with complete haematopoetic recovery. Total-body radiation with 3.6 Gy in four patients, cyclosporin A administration to ten patients and buffy-coat transfusion to nine patients entirely prevented early rejection. Two patients died of pneumonia (aspergillus; varicella-zoster virus), one patient died of bleeding from a splenic-artery aneurysm. In patients under the age of 40 years with severe aplastic anaemia bone marrow transplantation as early as possible after diagnosis is the treatment of choice if HLA-identical siblings are available as donors. In patients over 40 years treatment should at first be tried with antithymocyte globulin.
对15例(年龄5 - 39岁)重型再生障碍性贫血患者进行了骨髓移植。12例患者在移植后76 - 1930天(中位数668天)存活,造血功能完全恢复。4例患者接受了3.6 Gy的全身照射,10例患者使用了环孢素A,9例患者进行了白膜层输血,这些措施完全预防了早期排斥反应。2例患者死于肺炎(曲霉菌;水痘 - 带状疱疹病毒),1例患者死于脾动脉瘤出血。对于40岁以下的重型再生障碍性贫血患者,如果有HLA相同的同胞供者,诊断后尽早进行骨髓移植是首选治疗方法。对于40岁以上的患者,首先应尝试使用抗胸腺细胞球蛋白进行治疗。